Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program
Merrill P.T., Clark W.L., Banker A.S., Fardeau C., Franco P., LeHoang P., Ohno S., Rathinam S.R., Ali Y., Mudumba S., Shams N., Nguyen Q.D., Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Study Group
View publication
-
Therapeutic Area
Back of the eye (BOTE)
-
Categories
Clinical development
-
Affiliations
Department of Ophthalmology, Rush University Medical Center, Chicago, IL, United States; Department of Ophthalmology, Palmetto Retina Center, LLC, West Columbia, SC, United States; Banker's Retina Clinic and Laser Center, Navrangpura, Ahmedabad, India; Department of Ophthalmology, Pitie-Salpetriere Hospital, Sorbonne University, Paris, France; Organización Médica de Investigación, Buenos Aires, Argentina; Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan; Department of Uveitis Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India; Ribomic USA Inc., Berkeley, CA, United States; Global Biomedical Strategy and Research, Santen, Inc., Emeryville, CA, United States; Global Research and Development, Santen, Inc., Emeryville, CA, United States; Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, United States